Kabra Drugs Limited (BOM:524322)
India · Delayed Price · Currency is INR 27.17
+0.19 (0.70%)
At close: Jan 22, 2026
Kabra Drugs Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2016 - 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | 2016 - 2020 |
Cash & Equivalents | 116.1 | 212.99 | 26.71 | 0.03 | 0.01 | 0.1 | Upgrade |
Short-Term Investments | 0.89 | 0.44 | 0.44 | - | - | - | Upgrade |
Cash & Short-Term Investments | 116.99 | 213.43 | 27.15 | 0.03 | 0.01 | 0.1 | Upgrade |
Cash Growth | 460.19% | 686.23% | 91932.82% | 133.67% | -87.10% | -10.75% | Upgrade |
Accounts Receivable | 205.9 | 6.01 | 6.01 | 6 | 6 | 12.55 | Upgrade |
Receivables | 205.9 | 6.01 | 6.01 | 6.44 | 6.72 | 13.26 | Upgrade |
Inventory | 165.24 | - | - | - | - | - | Upgrade |
Other Current Assets | 43.87 | 32.19 | 12.33 | 0.33 | 0.33 | 0.33 | Upgrade |
Total Current Assets | 531.99 | 251.62 | 45.48 | 6.8 | 7.06 | 13.69 | Upgrade |
Property, Plant & Equipment | 7.05 | 0.44 | - | - | - | 0.1 | Upgrade |
Other Long-Term Assets | 0 | 0.23 | 0.23 | 0.23 | 0.23 | 0.23 | Upgrade |
Total Assets | 545.02 | 252.29 | 45.72 | 7.04 | 7.3 | 14.02 | Upgrade |
Accounts Payable | 275.88 | - | - | - | - | 1.87 | Upgrade |
Short-Term Debt | 4.69 | 4.37 | 17.09 | 13.82 | 10.26 | 9 | Upgrade |
Other Current Liabilities | 0.8 | 1.37 | 17.8 | 0.53 | 0.97 | 5.22 | Upgrade |
Total Current Liabilities | 284.63 | 5.74 | 34.89 | 14.35 | 11.23 | 16.1 | Upgrade |
Long-Term Deferred Tax Liabilities | 0.01 | 0.01 | - | - | - | - | Upgrade |
Other Long-Term Liabilities | 0.47 | - | -0 | 0 | 0 | - | Upgrade |
Total Liabilities | 285.1 | 5.74 | 34.89 | 14.35 | 11.23 | 16.1 | Upgrade |
Common Stock | 237.08 | 237.08 | 43.89 | 43.89 | 43.89 | 43.89 | Upgrade |
Retained Earnings | 22.84 | 9.47 | -58.56 | -51.2 | -47.82 | -45.96 | Upgrade |
Comprehensive Income & Other | - | -0 | 25.5 | - | - | - | Upgrade |
Shareholders' Equity | 259.92 | 246.55 | 10.83 | -7.31 | -3.93 | -2.08 | Upgrade |
Total Liabilities & Equity | 545.02 | 252.29 | 45.72 | 7.04 | 7.3 | 14.02 | Upgrade |
Total Debt | 4.69 | 4.37 | 17.09 | 13.82 | 10.26 | 9 | Upgrade |
Net Cash (Debt) | 112.29 | 209.06 | 10.06 | -13.79 | -10.25 | -8.91 | Upgrade |
Net Cash Growth | 675.46% | 1977.87% | - | - | - | - | Upgrade |
Net Cash Per Share | 5.84 | 19.13 | 2.29 | -3.14 | -2.33 | -2.03 | Upgrade |
Filing Date Shares Outstanding | 23.85 | 23.71 | 4.39 | 4.39 | 4.39 | 4.39 | Upgrade |
Total Common Shares Outstanding | 23.85 | 23.71 | 4.39 | 4.39 | 4.39 | 4.39 | Upgrade |
Working Capital | 247.36 | 245.88 | 10.6 | -7.54 | -4.16 | -2.41 | Upgrade |
Book Value Per Share | 10.90 | 10.40 | 2.47 | -1.67 | -0.90 | -0.47 | Upgrade |
Tangible Book Value | 259.89 | 246.55 | 10.83 | -7.31 | -3.93 | -2.08 | Upgrade |
Tangible Book Value Per Share | 10.89 | 10.40 | 2.47 | -1.67 | -0.90 | -0.47 | Upgrade |
Machinery | - | 0.44 | - | 1.66 | 1.66 | 1.66 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.